CoChat

A secondary drug resistance mutation of TEM-1 β-lactamase that suppresses misfolding and aggregation

Open access
Sideraki, Vera, Huang, Wanzhi, Palzkill, Timothy, Gilbert, Hiram F. · 2001 · Proceedings of the National Academy of Sciences
Cited by 121

The DOI matches its Crossref record.

Abstract

In Gram-negative bacteria, TEM-1 β-lactamase provides the major mechanism of plasmid-mediated β-lactam resistance. Natural variants of TEM-1 with increased antibiotic resistance have appeared in response to the use of extended-spectrum β-lactam antibiotics (e.g., ceftazidime) and β-lactamase inhibitors (e.g., clavulanic acid). Some of the variant enzymes are more efficient at catalyzing β-lactam hydrolysis, whereas others are more resistant to inhibitors. M182T is a substitution observed in both types of variant TEM-1 β-lactamases. This mutation is found only in combination with other amino acid substitutions, suggesting that it may correct defects introduced by other mutations that alter the specificity. An engineered core mutation, L76N, which diminishes the periplasmic β-lactamase activity by 100-fold, was used as a model to understand the mechanism of suppression of the M182T mutation. Biochemical studies of the L76N enzyme alone and in combination with the M182T mutation indicate that the M182T substitution acts at the level of folding but does not affect the thermodynamic stability of TEM-1 β-lactamase. Thus, the M182T substitution is an example of a naturally occurring mutation that has evolved to alter the folding pathway of a protein and confer a selective advantage during the evolution of drug resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.98.1.283

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 121

Metadata

Authors
Sideraki, V., Huang, W., Palzkill, T., & Gilbert, H. F.
Venue
Proceedings of the National Academy of Sciences
Published
2000-12-12
Volume
98
Issue
1
Pages
283-288
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2161777203
Cited by
121
References
0
FWCI
2.54
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A secondary drug resistance mutation of TEM-1 β-lactamase that suppresses misfolding and aggregation. https://app.cochat.ai/papers/10.1073/pnas.98.1.283
The paper
Sideraki, V., Huang, W., Palzkill, T., & Gilbert, H. F. (2001). A secondary drug resistance mutation of TEM-1 β-lactamase that suppresses misfolding and aggregation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.98.1.283

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.